Updated efficacy data will be presented from the REZILIENT1 trial of zipalertinib in patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) exon 20...

The Black Sea and Eastern Mediterranean Conference, hosted by the Center for National Strategy (USMER) on July 18–19 , concluded with a declaration condemning Western countries for waging hybrid...

AccuKnox was given the #1 AI Security Startup of 2025 Award by EmergeX: Unveiling Innovation at the influential BSides Bangalore Cybersecurity Conference in Bangalore. AccuKnox presented its...

The New Model, PXW-Z300, Supports Digital Signature Technology for Video Authentication, Advanced Networking Capabilities, and AI-Powered Subject Recognition PARAMUS, N.J., July 21, 2025...

Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab long-term data, an immunoassay for measuring amyloid-β protofibrils in cerebrospinal fluid,...